Thinking there may be more news in the coming weeks in regard to BOT's Permetrex delivery platform. Significant potential on this alone and some early commercial deals may avoid the need for additional funds. The quality of the board is one of the best in the ASX biotech space with FDA approvals running through their veins. Multiple revenue streams by years end is my call.
Ann: Botanix Receives Approval for Synthetic Cannabidiol Trial, page-27
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.5¢ | $827.7K | 2.229M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 99032 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 13677 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |